News Concordia hiked drug price by 6,000%, says UK watchdog CMA provisionally finds Concordia overpriced thyroid drug.
News Concordia and Actavis face UK pricing probe Firms colluded to hike prices, says competition watchdog.
News Lilly's tirzepatide juggernaut is still gathering momentum Lilly shrugs off concerns about the effect of US drug pricing policies on its diabetes and weight loss drugs as revenues leap 39% to $24.4bn.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
